Molecular Pathology and Targeted Therapy Quiz
{"name":"Molecular Pathology and Targeted Therapy Quiz", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?, For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?, Please enter your email address","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}